Search

Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease

Trial Phase 1 Unknown July 9, 2020

Validation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson's Disease

Trial N/A Completed July 7, 2020

Cognitive Decline in Non-demented PD

Trial Phase 4 Completed July 6, 2020

Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects

Trial Phase 1 Terminated July 6, 2020

SMARTfit Training for Parkinson's Disease

Trial N/A Terminated July 6, 2020

Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

Trial Phase 3 Completed July 1, 2020

Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine

Trial Phase 3 Unknown June 30, 2020

A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease

Trial N/A Unknown June 30, 2020

Probiotics-prebiotic Fiber Therapy in Parkinson's Disease Patients With Constipation

Trial Phase 3 Completed June 29, 2020

Transcranial Direct Current Stimulation for Freezing of Gait

Trial N/A Terminated June 29, 2020

Spinal Cord Stimulation for Gait in Parkinson Disease

Trial N/A Unknown June 22, 2020

Cycling Deep Brain Stimulation on Parkinson's Disease Gait

Trial N/A Unknown June 22, 2020

LRRK2 G2385R Leucocyte and Urine Biomarker Study

Trial N/A Unknown June 17, 2020

Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease

Trial N/A Completed June 17, 2020

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Trial Phase 3 Withdrawn June 16, 2020

An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)

Trial N/A Unknown June 16, 2020

Repetitive Transcranial Magnetic Stimulation for the Treatment of Freezing of Gait in Parkinson's Disease

Trial N/A Unknown June 15, 2020

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease

Trial Phase 2 Completed June 15, 2020

A Study to Investigate a New Treatment in Patients With Parkinson's Disease

Trial Phase 1 Completed June 15, 2020

Sublingual Photobiomodulation in Parkinson's Disease

Trial N/A Unknown June 11, 2020